The global Dog Vaccines market has witnessed steady growth over the past few years owing to rising awareness about pet healthcare and preventable diseases. Dog Vaccines help prevent several life-threatening illnesses like rabies, hepatitis, distemper, parvovirus and leptospirosis. Growing humanization of pets and rising disposable incomes have encouraged people to spend more on vet care and vaccination of their pet dogs. Various vaccines combinations are available depending on the risk of exposure to certain diseases. For example, core vaccines aim to protect against diseases widespread in the canine population while non-core vaccines focus on diseases less prevalent in certain regions.

The Global Dogs Vaccines Market is estimated to be valued at USD 2.21 Bn in 2025 and is expected to reach USD 3.52 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032

The  Dog Vaccines Market Growth manufacturers are focusing on geographical expansion and capacity extension to tap lucrative markets worldwide. For instance, Merial recently expanded its NC, US facility to ramp up production of its core vaccines comprising Vanguard and Proheartbeat. Likewise, Zoetis is strengthening its presence across Europe and Asia Pacific through partnerships and acquisitions.

Get More Insights On-Dog Vaccines Market